Counterpoint Mutual Funds LLC Purchases New Position in Teladoc Health, Inc. $TDOC

Key Points

• Counterpoint Mutual Funds LLC has acquired a new position in Teladoc Health, Inc., purchasing 42,889 shares valued at approximately $374,000 in the second quarter.
• Bank of America has lowered its price target for Teladoc Health from $8.00 to $7.00, while Mizuho set a new price target of $10.00, indicating mixed analyst opinions on the stock.
• Teladoc reported revenue of $631.90 million for the last quarter, exceeding analysts' expectations, but its earnings per share remained negative at ($0.19).

Counterpoint Mutual Funds LLC acquired a new position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 42,889 shares of the health services provider's stock, valued at approximately $374,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC grew its stake in shares of Teladoc Health by 102.6% during the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after buying an additional 1,690 shares during the last quarter. National Bank of Canada FI boosted its holdings in shares of Teladoc Health by 79.4% during the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after acquiring an additional 1,581 shares in the last quarter. SVB Wealth LLC bought a new stake in Teladoc Health during the 1st quarter worth $37,000. BI Asset Management Fondsmaeglerselskab A S acquired a new position in Teladoc Health in the 1st quarter worth about $50,000. Finally, Quantitative Investment Management LLC bought a new position in Teladoc Health in the first quarter valued at about $82,000. Institutional investors and hedge funds own 76.82% of the company's stock.

Analysts Set New Price Targets

TDOC has been the topic of several research reports. Bank of America reduced their price target on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a report on Wednesday, May 28th. Mizuho began coverage on shares of Teladoc Health in a research report on Friday, July 25th. They set a "neutral" rating and a $10.00 target price on the stock. Evercore ISI boosted their target price on shares of Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a report on Wednesday, July 9th. Finally, Truist Financial dropped their price target on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research note on Tuesday, May 27th. Six analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $9.80.

Teladoc Health Trading Up 2.4%

TDOC opened at $8.39 on Wednesday. The stock has a market cap of $1.48 billion, a PE ratio of -7.05 and a beta of 1.84. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. Teladoc Health, Inc. has a twelve month low of $6.35 and a twelve month high of $15.21. The company has a fifty day moving average of $7.66 and a 200-day moving average of $7.62.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The firm had revenue of $631.90 million during the quarter, compared to the consensus estimate of $621.91 million. During the same period last year, the business posted ($0.38) EPS. The business's revenue was down 1.6% compared to the same quarter last year. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, sell-side analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.